General Archive
-
News releasesDementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments
The Dementia Consortium, a public-private partnership initiative bridging the gap between academic research and the pharmaceutical industry, is supporting a…
-
News releases
MRC Technology licenses antibody to Newsummit Biopharma for development of Hepatitis C virus infection therapeutic
MRC Technology has licensed an antibody to Newsummit Biopharma for development of a novel therapeutic for treatment of Hepatitis C…
-
News releases
MRC Technology joins project UTILE to enable medical breakthroughs from European funded research
MRC Technology is committed to ensuring that promising medical research is protected and progressed to benefit patients. We are therefore…
-
News releases
MRC Technology appoints Steve Visscher as new trustee
MRC Technology has appointed Steve Visscher CBE to its board of trustees.
-
News releases
MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets…
-
News releases
MRC Technology invests £7 million to expand its diagnostics research capability in Scotland
MRC Technology, an independent medical research charity, has announced the relocation of its Centre for Diagnostics Development (CDD) to Nine,…
-
News releases
MRC Technology, UCB and the University of Leicester combine research excellence and expertise to evolve drug discovery
New research consortium aims to identify opportunities for drug discovery through the innovative use of antibodies in structure-based drug discovery…
-
News releases
New collaboration to explore novel treatments for respiratory diseases
A charity-industry collaboration has launched an initiative to find new epigenetic drug treatments to improve the lives of millions of…
-
News releases
MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital
MRC Technology has monetised a portion of its royalty interest in a leading cancer drug, pembrolizumab (marketed by Merck &…
-
News releases
MRC Technology and Keio University to collaborate on drug discovery
MRC Technology and Keio University School will collaborate to identify promising antibody and small molecule research and translate them into…
-
News releases
Patent protection for biotech/genetic engineering: report
Andrew Farquarson, Director, Technology Transfer, has been a member of the EU Commission’s Expert Group appointed in 2012 to advise on…
-
News releases
Enhancing patient benefit from research spending: MRC Technology and DEBRA Austria sign agreement
MRC Technology, a medical research charity, has signed an agreement to review DEBRA Austria’s research portfolio, aiming to identify promising…